What is AICAR?
AICAR is a small molecule that activates the enzyme AMPK, the cell's central energy sensor. It is seen as an exercise-mimetic candidate: part of the metabolic signals otherwise produced by endurance training is meant to be triggered without training.
Up front: the spectacular effects come from animal models, there is no established, sensible human dose.
Comparison
Exercise mimetic candidates compared
Compounds from the TPD lexicon meant to mimic training signals, as described there. Tap a card to open its entry.
Simplified: AICAR acts on AMPK, cardarine on the PPAR delta receptor. Both routes were tested in the 2008 mouse study. There is no comparison in humans. 1
How it works
By activating AMPK, AICAR switches on programs tied to energy expenditure, fat burning and endurance. In mice AICAR markedly increased running endurance even without training (Narkar, 2008). But the effect in humans at reasonable doses is unclear.
Where it acts
Where AICAR acted in studies
Tap a point or a card. Colour = AMPK, grey = observed. Only tested in humans as an infusion.
- Skeletal muscle
More endurance in mice, more sugar uptake into muscle of healthy men (infusion)3
AMPK - Blood
Rapid uptake into red blood cells and conversion to the monophosphate, half-life 1.4 hours2
Observed in trials - Heart
No protection against complications in bypass surgery (phase 3)4
Observed in trials - Kidney
Kidney problems with very high infusions in leukaemia studies5
Observed in trials
Targets in the ChEMBL database8
Compound CHEMBL1551724 (Acadesin): one recorded mechanism, Activator according to ChEMBL.
- Gene
- PRKAA1, PRKAA2
- UniProt
- Q13131, P54646
- ChEMBL
- CHEMBL2096907
- Action
- Activator according to ChEMBL
What you need
Supplies
2 things, numbered as in the picture
Tick off what you already have. Vial and BAC water are our real shop photos at the same size.
-
AICAR vial
The AICAR vial (lyophilized powder).
-
Water and supplies
Bacteriostatic water, U-100 insulin syringes, alcohol swabs.
Reconstitution
Use the peptide calculator. A 50mg vial with 2ml water gives 25mg per ml. Just add the water to the vial and let it dissolve.
Step by step
Dissolving the powder
Four steps, the same for every vial size.
- 1Wipe the cap
Clean the rubber stopper with an alcohol swab.
- 2Add BAC water
Just add it, it does not matter if it hits the powder directly.
- 3Swirl or shake
Until everything has dissolved, both are fine.
- 4Draw up
With the U-100 insulin syringe.
Dosing
Dosing
Dosing, titration and syringe
Loading the dosing information …
- Getting started and stepping up, drawn as a staircase
- Units on the U-100 syringe for every step
- How long one vial lasts
Injection
The injection is subcutaneous, into the fat layer under the skin. Common spots are the abdomen (keep about two finger-widths clear of the navel), the front and the inner side of the thigh, or the back of the upper arm.
The short version:
Injection
Where and at what angle
Pick a spot or switch the angle. Subcutaneous means: into the fat layer, not the muscle.
Rotate the spot each time, never the same one twice in a row.
Rule of thumb: where there is more fat under the skin, insert straight at 90 degrees. In lean people with little fat, 45 degrees, so the needle stays in the fat layer. Simplified diagram.
-
Clean the spot with an alcohol swab and let it dry
-
Pinch up a small fold of skin
-
Insert the needle: at 90 degrees where there is more fat under the skin, at 45 degrees in lean people with little fat
-
Inject slowly, wait a moment, then withdraw
-
Put the needle straight into the sharps container
Rotate the site each time so the tissue does not get irritated. Never the same spot twice in a row.
What the research shows
The well-known study (Narkar, 2008) showed in mice that AICAR alone, without training, raised running endurance by 44 percent after 4 weeks, a classic exercise-mimetic result. The combination with training was tested there with a different compound (a PPAR-delta agonist). That is impressive but animal research at high doses. AICAR is also on the WADA list.
In humans AICAR, under the name acadesine, went as an infusion into a phase 3 study in heart bypass surgery (RED-CABG, Newman 2012). It was stopped early after 3,080 patients because no benefit was expected. There is no approval.
Study results
What the trials measured
Interactive: switch tabs, tap points, show or hide arms. Arms are named relative to each other, no dosing advice.
Running endurance of untrained mice after four weeks1
Change compared with mice without AICAR, in percent
Value from the abstract, daily dosing into the abdominal cavity according to the full text. The mice did not train, AICAR switched on metabolic genes in muscle. The animals received high doses. Mouse model, not tested in humans.
Sugar uptake into muscle of healthy men3
Rise after three hours compared with baseline, as a multiple
Values from the abstract, 29 healthy men. AICAR was given as an infusion into a vein, not under the skin. Whole-body glucose disposal rose by only 7 percent and AMPK activity in muscle did not change measurably.
Death, stroke or severe heart failure up to day 284
Share of participants in percent, 1,493 per group
Values from the abstract. The trial was stopped after 3,080 of a planned 7,500 participants because an interim analysis made a benefit unlikely. The key secondary endpoints showed no difference either.
Research status
Where the research stands
The registry lists five trials with AICAR or acadesine, all using the compound as an infusion or lab tool, none with injections under the skin. Shown are the three acadesine trials with a start and end date in the registry. As of 26 Oct 2026. 7
- Preclinical Cell assays and mouse models, exercise mimetic study 2008
- Phase 1 no registered trial
- Phase 2 2 trials, 1 completed, 1 stopped early
- Phase 3 1 trial, 0 completed, 1 stopped early
- Approval not yet
Show all 3 phase 2 and 3 trials on a timelineHide timeline
NCT00559624 · 40 participants (planned), started Dec 2007, primary endpoint reached Dec 2010.
Registry entry ↗ · Results: Van Den Neste et al., Cancer Chemotherapy and Pharmacology, 2013
NCT01813838 · 5 participants, started Jun 2013, stopped early Jun 2013.
RED-CABG · NCT00872001 · 3,080 participants, started Apr 2009, stopped early Oct 2010.
Registry entry ↗ · Results: Newman et al., JAMA, 2012
Bar: start to primary endpoint (planned for running trials). Green = completed, blue = progress until 26 Oct 2026, grey = stopped early.
Side effects
- Solid human data are largely missing.
- Local reactions at the injection site.
- Banned in official competition.
Storage
Before mixing the powder is robust, normal room temperature (around 20 to 25 degrees) is fine, ideally kept in the dark. After mixing, keep in the fridge (2 to 8 degrees), do not freeze. It stays good there for at least 4 to 6 months with barely any loss of potency, in practice considerably longer. Swirl or shake to mix, both are fine.
Shelf life
How long it keeps
Robust, no fridge needed. Best kept in the dark.
At least 4 to 6 months with barely any loss of potency. The bacteriostatic water brings a preservative.
- Keep it dark
- Dissolved: 2 to 8 degrees
- Note the mixing date on the vial